Mid Europa’s Walmark acquires Valosun

Mid Europa Partners-owned Czech dietary supplements maker Walmark has bolted on probiotics manufacturer Valosun.

The acquisition of Valosun will expand Walmark's offering in the Czech Republic and Slovakia, which are the bolt-on's main markets.

Mid Europa took a 50% stake in Walmark in July 2012 through the GP's 2007-vintage €1.5bn third fund.

Valosun is the first add-on acquisition for Walmark.

Company
Founded in 1997, Valosun is a Brno-headquartered maker of probiotics and natural remedies.

The company's main markets are the Czech Republic and Slovakia, but it also sells its products across Europe and in parts of Asia.

People
Mid Europa director Robert Chmelar led the transaction, with the firm's Viktoria Habanova and Tomas Vrba supporting Walmark's management.

Advisers
Equity – Patria (Corporate finance); White & Case (Legal); Deloitte (Financial due diligence).

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater